BriaCell Therapeutics - President and CEO, Bill Williams (left)

" BriaCell (TSX:BCT) signs research agreement to identify novel targets for cancer treatment

BriaCell Therapeutics (BCT) has announced a research collaboration with Harvard Medical School, supporting a project led by Joan S. Brugge, Ph.D.

" BriaCell (TSX:BCT) advances towards new breast cancer treatment clinical trial

BriaCell Therapeutics Corp. (BCT) is manufacturing its novel off-the-shelf (OTS) personalized immunotherapy, Bria-OTS™, a treatment against advanced breast cancer.
BriaCell Therapeutics - Marc Lustig, Board of Directors

" Marc Lustig joins BriaCell Therapeutics’ (TSXV:BCT) Board of Directors

BriaCell Therapeutics (BCT) welcomes Mr. Marc Lustig to the company’s Board of Directors, effective September 1, 2021.
BriaCell Therapeutics - President and CEO, Bill Williams (left)

" BriaCell (TSXV:BCT) expands breast cancer technology

BriaCell Therapeutics (BCT) has expanded its breast cancer platform technology into prostate, melanoma and lung cancers.